Durability of Response to Primary Chemoablation of Low-Grade UTUC Using UGN-101
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report
J Urol 2022 Apr 01;207(4)779-788, SF Matin, PM Pierorazio, N Kleinmann, JL Gore, A Shabsigh, B Hu, K Chamie, G Godoy, SG Hubosky, M Rivera, M O'Donnell, M Quek, JD Raman, JJ Knoedler, D Scherr, C Weight, A Weizer, M Woods, H Kaimakliotis, AB Smith, J Linehan, J Coleman, MR Humphreys, R Pak, D Lifshitz, M Verni, I Klein, M Konorty, D Strauss-Ayali, G Hakim, E Seltzer, M Schoenberg, SP LernerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.